4.7 Article

High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions The CANHEART Study

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 68, Issue 19, Pages 2073-2083

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2016.08.038

Keywords

cardiac and noncardiac death; epidemiology; outcomes; risk factor; sociodemographic

Funding

  1. Chronic Diseases Team grant from the Institute of Circulatory and Respiratory Health-Canadian Institutes of Health Research [TCA 118349]
  2. Institute for Clinical Evaluative Sciences
  3. Ontario Ministry of Health and Long-Term Care
  4. Clinician Scientist Award from the Heart and Stroke Foundation, Ontario office
  5. Career Investigator Awards from the Heart and Stroke Foundation, Ontario office
  6. Canadian Institutes of Health Research
  7. Heart and Stroke Foundation
  8. Clinician-Scientist Award from Canadian Institutes of Health Research
  9. Distinguished Clinical Scientist Award from the Heart and Stroke Foundation of Canada
  10. Canada Research Chair in Health Services Research
  11. Eaton Family Scholar award

Ask authors/readers for more resources

BACKGROUND The prognostic importance of high-density lipoprotein cholesterol (HDL-C) as a specific risk factor for cardiovascular (CV) disease has been challenged by recent clinical trials and genetic studies. OBJECTIVES This study sought to reappraise the association of HDL-C level with CV and non-CV mortality using a big data approach. METHODS An observational cohort study was conducted using the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) dataset, which was created by linking together 17 different individual-level data sources. People were included if they were between 40 and 105 years old on January 1, 2008, living in Ontario, Canada, without previous CV conditions or severe comorbidities, and had an outpatient fasting cholesterol measurement in the year prior to the inception date. The primary outcome was cause-specific mortality. RESULTS A total of 631,762 individuals were included. The mean age of our cohort was 57.2 years, 55.4% were women, and mean HDL-C level was 55.2 mg/dl. There were 17,952 deaths during a mean follow-up of 4.9 +/- 0.4 years. The overall all-cause mortality rate was 8.1 per 1,000 person-years for men and 6.6 per 1,000 person-years for women. Individuals with lower HDL-C levels were more likely to have low incomes, unhealthy lifestyle, higher triglycerides levels, other cardiac risk factors, and medical comorbidities. Individuals with lower HDL-C levels were independently associated with higher risk of CV, cancer, and other mortality compared with individuals in the reference ranges of HDL-C levels. In addition, individuals with higher HDL levels (>70 mg/dl in men, >90 mg/dl in women) had increased hazard of non-CV mortality. CONCLUSIONS Complex associations exist between HDL-C levels and sociodemographic, lifestyle, comorbidity factors, and mortality. HDL-C level is unlikely to represent a CV-specific risk factor given similarities in its associations with non-CV outcomes. (C) 2016 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available